Molecular mechanisms underlying IFN-γ-mediated tumor growth inhibition induced during tumor immunotherapy with rlL-12

International Immunology

Volumn 8, Issue 6, 1996, Pages 855-865

  Yu, Wen Gong ^a   Yamamoto, Norihiko ^a   Takenaka, Hiroshi ^a   Mu, Jie ^a   Tai, Xu Guang ^a   Zou, Jian Ping ^a   Ogawa, Makoto ^a   Tsutsui, Tateki ^a   Wijesuriya, Rishani ^a   Yoshida, Ryotaro ^b   Herrmann, Steven ^c   Fujiwara, Hiromi ^a   Hamaoka, Toshiyuki ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

^b OSAKA BIOSCIENCE INSTITUTE   (Japan)

^c PFIZER INC   (United States)

Author keywords

IFN ; IL 12; Inducible NO synthase; Tumor immunity

Indexed keywords

CD11B ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INDOLEAMINE 2,3 DIOXYGENASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RECOMBINANT INTERLEUKIN 12; TRYPTOPHAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CANCER REGRESSION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION; GENE INDUCTION; LYMPHOID CELL; MALE; MOUSE; NONHUMAN; OVARY CARCINOMA; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR GROWTH;

ANIMALS; CARCINOMA; CHEMOTAXIS, LEUKOCYTE; FEMALE; FIBROSARCOMA; GENE EXPRESSION REGULATION; GRAFT REJECTION; GROWTH INHIBITORS; IMMUNOTHERAPY, ACTIVE; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERFERON TYPE II; INTERLEUKIN-12; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OVARIAN NEOPLASMS; RECOMBINANT PROTEINS; RNA, MESSENGER; TRYPTOPHAN OXYGENASE; TUMOR CELLS, CULTURED;

EID: 0029990630     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/8.6.855     Document Type: Article

References (54)

1. Kobayashi, M., Fitz, L., Ryan, M., Hewick, R. M., Clark. S. C., Chan, S., Loudon, R., Sherman, F., Perussia, B. and Trinchieri, G. 1989. Identification and purification of natural killer cell stimulatory factor (NKSF). a cytokine with multiple biological effects on human lymphocytes. J. Exp. Med. 170:827
2. Stern, A. S., Podlaski, F. J., Hulmes, J. D., Pan, Y-C. E., Quinn, P. M., Wolitzky, A. G., Familletti, P. C., Stremlo, D. L., Truitt, T., Chizzonite, R. and Gately, M. K. 1990. Purification to homogeneity and partial characterization of cytoloxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc. Natl Acad. Sci. USA 87:6808.
3. Wolf, S. F., Temple, P. A., Kobayashi, M., Young, D., Dicig, M., Lowe, L., Dzialo, R., Fitz, L., Ferenz, C., Hewick, R. M., Kelleher, K., Herrmann, S. H., Clark, S. C., Azzoni, L., Chan, S. H., Trinchieri, G. and Perussia, B. 1991. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J. Immunol. 146:3074.
4. Gubler, U., Chua, A. O., Schoenhaut, D. S., Dwyer, C. M., McComas, W., Motyka, R., Nabavi, N., Wolitzky, A. G., Quinn, P. M., Familletti, P. C. and Gately, M. K. 1991. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc. Natl Acad. Sci. USA 88:4143
5. Robertson, M. J., Soiffer, R. J., Wolf, S. F., Manley, T. J., Donahue, C., Young, D., Herrmann, S. H. and Ritz, J. 1992. Responses of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:779
6. Gately, M. K., Desai, B. B., Wolitzky, A. G., Quinn, P. M., Dwyer, C. M., Podlaski, F. J., Familletti, P. C., Sinigaglia, F., Chizonnite, R., Gubler, U. and Stern, A. S. 1991. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J. Immunol. 147:874.
7. +, TCR-γδ T lymphocytes and NK cells. J. Immunol. 149:3495.
8. Chan, S. H., Perussia, B., Gupta, J. W., Kobayashi, M., Pospisil, M., Young, H. A., Wolf, S. F., Young, D., Clark, S. C. and Trinchieri, G. 1991. Induction of interferon γ production by natural killer cell stimulatory factor: characterization of the responding cells and synergy with other inducers. J. Exp. Med. 173:869.
9. Manetti, R., Parronchi, P., Giudizi, M. G., Piccinni, M. P., Maggi, E., Trinchieri, G. and Romagnani, S. 1993. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J. Exp. Med. 177:1199.
10. Trinchieri, G. 1993, Interleukin-12 and its role in the generation of TH1 cells, Immunol Today 14:335.
11. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F. and Gately, M. K. 1993. Antitumor and antimetastatic activity of interleukin-12 against murine tumors. J. Exp. Med. 178:1223.
12. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Stewart, W. T., Storkus, J. and Lotze, M. T. 1994. Recombinant interleukin-12 (IL-12) administration induces tumor regression in association with interferon-γ production. J. Immunol. 153:1697.
13. Zou, J-P, Yamamoto, N., Fujii, T., Takenaka, H., Kobayashi, M., Herrmann, S. H., Wolf, S. F., Fujiwara H. and Hamaoka, T., 1995. Systemic administration of rIL-12 induces complete tumor regression and protective immunity: response is correlated with a striking reversal of suppressed interferon-γ production by antitumor T cells. Int. Immunol. 7:1135.
14. Natnan, C. and Yoshida, R. 1988, Cytokines: interferon-γ. In Galin, J. I., Goldstein, I. M. and Snyderman, R. eds, Inflammation: Basic Principles and Clinical Correlates, p. 229. Raven Press, New York.
15. Chen, L. K., Tourveille, B., Burns, G. R, Bach, F. H., Matieu-Mahul, D., Sasportes, M and Bensussan. A. 1986. Interferon: a cytotoxic T-lymphocyte differentiation signal. Eur J. Imrnunol. 16:767.
16. Maraskovsky, E., Chen, W. F. and Shortman, K. 1989 IL-2 and IFN-γ are two necessary lymphokines in the development of cytotoxic T-cells. J. Immunol. 143:1210
17. Wallach, D., Fellous, M. and Revel, M 1982. Preferential effect of interferon-γ on the synthesis of HLA antigens and their mRNAs in human cells. Nature 299:833.
18. Celada, A, and Maki, R. A. 1991. IFN-γ induces the expression of the genes for MHC class II I-Ab and tumor necrosis factor through a protein kinase C-independent pathway, J. Immunol. 146:114.
19. Sugarman, B. J., Aggarwal, B. B. and Figari, I. S. 1985. Recombinant human tumor necrosis factor-a: effects on proliferation of normal and transformed cells in vitro. Science 230:943.
20. Yoshida, T. O., Haraguchi, S., Miyamoto, H. and Matsuo, T. 1979. Recognition of RSV-induced tumor cells in syngeneic mice and semisyngeneic reciprocal hybrid mice Gann Monograph Cancer Res. 23:201.
21. Hashimoto, M., Niwa, O., Nitta, Y., Takeichi, M. and Yokoro, K. 1989. Unstable expression of E-cadherin adhesion molecules in metastatic ovarian tumor cells. Jpn. J. Cancer Res. 80:450
22. Ogata, M., Shimizu, J., Kosaka, H., Maekawa, R., Shimizu, K., Fujiwara, H. and Hamaoka, T 1986. Expression of H-2 antigens and inducibility of anti-tumor immune responses in various tumor cell clones established from methylcholanthrene-induced fibrosarcoma, Jpn. J. Cancer Res. 77:1134.
23. Ding, A. H., Nathan, C. F. and Stuehr, D. J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages: comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
24. Xie Q-W., Cho, H. J., Calacay, J., Mumford, R. A., Swiderek, K. M., Lee, T. D., Ding, A., Troso, T. and Nathan, C. 1992. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 256:225.
25. Habara-Okubo, A., Takikawa, O. and Yoshida, R. 1991. Cloning and expression of a cDNA encoding mouse indoleamine 2,3-dioxygenase. Gene 105:221.
26. Wilson, K. C. and Finbloom, D. S. 1992. Interferon γrapidly induces in human monocytes a DNA-binding factor that recognizes the γ response region within the promoter of the gene for the high affinity Fcγ receptor. Proc. Natl Acad. Sci. USA 89:11964.
27. Lengyel, P 1982. Biochemistry of interferons and their actions. Annu. Rev. Biochem. 51:251.
28. Clemens. H. J. and McNurlan, M. A. 1985. Regulation of cell proliferation and differentiation by interferons. Biochem. J. 226:345.
29. Balkwill, F. R. and Burke, F. 1989. The cytokine network, Immunol. Today 10:299.
30. Shimizu, T., Nomiyama, S., Hirata, F. and Hayaishi, O. 1978. Indoleamine 2,3-dioxygenase. Purification and some properties. J. Biol. Chem. 253:700.
31. Yoshida, R., Imanishi, J., Oku, T., Kishida, T. and Hayaishi, O. 1981. Induction of pulmonary indoleamine 2,3-dioxygenase by interteron. Proc. Natl Acad. Sci. USA 78:129.
32. Ozaki, Y., Edelstein, M. P. and Duch, D. S. 1987. The actions of Interferon and antiinflammatory agents on induction of indoleamine 2,3-dioxygenase in human peripheral blood mononuclear cell cultures. J. Immunol. 139:2414.
33. Takikawa, O., Kuroiwa, T., Yamazaki, F. and Kido. R. 1988. Mechanism of interferon-γ action. Characterization of indoleamine 2,3-dioxygenase in cultured human cells induced by interferon-γ and evaluation of the enzyme mediated tryptopnan degradation in its anticellular activity. J. Biol. Chem. 263:2041.
34. Ozaki, Y., Edelstein, M. P. and Duch, D. S. 1988. Induction of Indoleamme 2,3-dioxygenase: a mechanism of the antitumor activity of interferon-γ. Proc. Natl Acad. Sci. USA 85:1242.
35. Burke, F., Knowles, R. G., East, N. and Balkwill, F. R. 1995. The role of indoleamine 2,3-dioxygenase in the anti-tumor activity of human interferon-γ in vivo. Int. J. Cancer 60:115.
36. Stuehr, D. J. and Griffith, O. W. 1992. Mammalian nitric oxide synthases. Adv. Enz. Rel. Areas Mol. Biol. 65:287
37. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051.
38. Marletta, M. A. 1993. Nitric oxide synthase structure and mechanism. J. Biol. Chem. 268:12241
39. Nathan, C. F. and Hibbs, J. B., Jr. 1991. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol. 3:65.
40. Moncada, S., Palmer, R. M. J. and Higgs, E. A. 1991. Nitric oxide: physiology, pathophysiology and pharmacology. Phamacol. Rev. 43:109.
41. Hibbs, J. B., Taintor, R. R., Chapman, H. A. and Weinberg, J. B. 1977. Macrophage tumor killing: influence of the local environment. Science 197:279.
42. Hibbs, J. B., Vavrin, Z. and Taintor, R. R. 1987. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells J. Immunol. 138:550.
43. Stuehr, D. J. and Nathan, C. F. 1989. Nitric oxide: a macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J. Exp. Med. 169:1543.
44. Ding, A. H., Nathan, C. F. and Stuehr, D. J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407.
45. Geller, D. A., Nussler, A. K., Disilvio, M., Lowenstein, C. J., Shapiro, R. A., Wang, S. C., Simmons, R. L. and Billiar, T. R. 1993 Cytokines, endotoxin, and glucocorticoids regulate the expression of inducible nitric oxide synthase in hepatocytes Proc. Natl Acad. Sci. USA 90:522.
46. Asano, K., Chee, C. B. E., Gaston, B., Lilly, C. M., Gerard, C., Drazen, J. M. and Stamler, J. S. 1994. Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. Proc. Natl Acad. Sci. USA 91:10089.
47. Hannun, Y. A. 1994. The sphingomyelin cycle and the second messenger function of ceramide. J. Biol. Chem 269:3125.
48. 3 in HL-60 cells: role in cell differentiation. J. Biol. Chem. 264:19076.
49. Gomez-Munoz, A., Martin, A., O'Brien, L. and Brindley, D. N. 1994. Cell-permeable ceramides inhibit the stimulation of DNA synthesis and phospholipase D activity by phosphatidate and lysophosphatidate in rat fibroblasts. J. Biol. Chem. 269:8937.
50. Jarvins, W. D., Kolesnick, R. N., Fornari, F. A., Traylor, R. S., Gewirtz, D. A. and Grant, S. 1994. Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl Acad. Sci. USA 91:73.
51. Kim, M-Y., Linardic, C., Obeid, L. and Hannun, Y. 1991. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor α and γ-interferon: specific role in cell differentiation. J. Biol. Chem. 266:484.
52. Obeid, L. M., Linardic, C. M., Karolak, L. A. and Hannun, Y. A. 1993 Programmed cell death induced by ceramide. Science 259:1769.
53. Mathias, S., Younes, A., Kan, C-C., Orlow, I., Joseph, C. and Kolesnick, R. N. 1993. Activation of the sphingomyelin pathway in intact EL4 cells and in a cell-free system by IL-1b. Science 259:519.
54. Farias-Eisner, R., Sherman, M. P., Aeberhard, E. and Chardhuri, G. 1994. Nitric oxide is an important mediator for tumoricidal activity in vivo. Proc. Natl Acad. Sci. USA 91:9407.